Patents by Inventor Shigekazu KURIHARA

Shigekazu KURIHARA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Immunostimulating agent
    Patent number: 10100008
    Abstract: Compounds represented by formula (I): wherein each symbol is as defined herein, have an immunostimulatory effect and are useful as immunostimulating agents, particularly as adjuvants, and for compositions containing such a compound, and for vaccines containing such a compound and an antigen.
    Type: Grant
    Filed: October 21, 2016
    Date of Patent: October 16, 2018
    Assignee: AJINOMOTO CO., INC.
    Inventors: Shigekazu Kurihara, Kenji Tanaka, Wataru Kurosawa, Hiroshi Umishio
  • IMMUNOSTIMULATING AGENT
    Publication number: 20180243421
    Abstract: Compounds represented by formula (I): defined herein and salts thereof, and compounds represented by formula (II): defined herein and salts thereof, exhibit superior immunostimulatory effects, and are useful as vaccine adjuvants and in vaccines containing such a compound and an antigen.
    Type: Application
    Filed: April 25, 2018
    Publication date: August 30, 2018
    Applicant: AJINOMOTO CO., INC.
    Inventors: Kenji TANAKA, Shigekazu KURIHARA, Wataru KUROSAWA, Hiroshi UMISHIO
  • IMMUNOSTIMULATING AGENT
    Publication number: 20170036999
    Abstract: Compounds represented by formula (I): wherein each symbol is as defined herein, have an immunostimulatory effect and are useful as immunostimulating agents, particularly as adjuvants, and for compositions containing such a compound, and for vaccines containing such a compound and an antigen.
    Type: Application
    Filed: October 21, 2016
    Publication date: February 9, 2017
    Applicant: AJINOMOTO CO., INC.
    Inventors: Shigekazu KURIHARA, Kenji TANAKA, Wataru KUROSAWA, Hiroshi UMISHIO
  • AGENT FOR ALLEVIATING SIDE EFFECTS IN CANCER CHEMOTHERAPY
    Publication number: 20160143871
    Abstract: Agents containing (A) cystine or a derivative thereof and (B) theanine, in combination, are useful for reducing side effects of cancer chemotherapy, can reduce various side effects of cancer chemotherapy, and can improve the treatment completion rate of cancer chemotherapy.
    Type: Application
    Filed: January 28, 2016
    Publication date: May 26, 2016
    Applicant: AJINOMOTO CO., INC.
    Inventors: Shigekazu KURIHARA, Takashi TSUCHIYA